Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Trevor J. Powles
Sign up to set email alerts
155
Publications
5,464
Citation Statements Received
1,138
Citation Statements Given
How they've been cited
9,628
166
5,284
14
How they cite others
2,521
69
1,064
5
Affiliations
Royal Marsden Hospital
,
Royal Marsden NHS Foundation Trust
Publications
Order By: Most citations
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
Cummings
1
,
Eckert
2
,
Krueger
3
et al.
2000
Obstetrical & Gynecological Survey
513
21
617
1
Get access via publisher
Add to collection
Cite
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Asselain
1
,
Barlow
2
,
Bartlett
3
et al.
2018
The Lancet Oncology
Abstract
Show
1,196
17
601
2
Get access via publisher
Add to collection
Cite
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004
Winer
1
,
Hudis
2
,
Burstein
3
et al.
2005
JCO
Abstract
Show
993
2
464
1
Get access via publisher
Add to collection
Cite
Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene
Martino
1
,
Cauley
2
,
Barrett‐Connor
3
et al.
2004
JNCI Journal of the National Cancer Institute
Abstract
Show
680
10
375
0
Get access via publisher
Add to collection
Cite
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Cuzick
1
,
Šestak
2
,
Bonanni
3
et al.
2013
The Lancet
Abstract
Show
486
2
369
1
Get access via publisher
Add to collection
Cite
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
Cauley
1
,
Norton
2
,
Lippman
3
et al.
2001
Breast Cancer Res Treat
Abstract
Show
647
15
316
0
Get access via publisher
Add to collection
Cite
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
Powles
1
,
Eeles
2
,
Ashley
3
et al.
1998
The Lancet
838
4
244
1
Get access via publisher
Add to collection
Cite
Lasofoxifene in Postmenopausal Women with Osteoporosis
Cummings
1
,
Ensrud
2
,
Delmas
3
et al.
2010
N Engl J Med
Abstract
Show
378
7
217
0
5
Get access via publisher
Add to collection
Cite
1
2
3
4